Finance

Beta
Lists
ACUTAAS:NSE
Acutaas Chemicals Ltd
₹3,169.00
+1.06%
(+33.30) 1D
Jun 4, 3:30:04 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ACUTAAS...
Open
₹3,136.00
High
₹3,188.00
Low
₹3,115.60
Mkt. cap
259.45B
Avg. vol.
496.96K
Volume
250.58K
P/E ratio
73.07
52-wk high
₹3,188.10
52-wk low
₹1,059.00
EPS
₹43.37
No. of employees
879
Open
₹3,136.00
High
₹3,188.00
Low
₹3,115.60
Mkt. cap
259.45B
Avg. vol.
496.96K
Volume
250.58K
P/E ratio
73.07
52-wk high
₹3,188.10
52-wk low
₹1,059.00
EPS
₹43.37
No. of employees
879
News stories
From sources across the web
About Acutaas Chemicals Ltd
CEO-
Employees879
Founded2007
Headquarters-
SectorPharmaceutical industry
Websiteacutaas.com
Last report
Apr 30, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
₹16.04 / ₹13.30
+20.60%beat
Revenue / Est. (INR)
4.33B / 4.10B
+5.47%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.07B
3.06B
3.93B
4.33B
Cost of goods sold
968.90M
1.35B
1.69B
1.64B
Cost of revenue
968.90M
1.35B
1.69B
1.64B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
250.73M
293.53M
298.57M
332.89M
Operating expense
675.70M
838.23M
831.79M
944.29M
Total operating expenses
1.64B
2.19B
2.52B
2.59B
Operating income
427.76M
869.21M
1.41B
1.74B
Other non operating income
159.38M
98.37M
46.99M
111.11M
EBT including unusual items
580.76M
961.80M
1.45B
1.84B
EBT excluding unusual items
580.76M
961.80M
1.45B
1.84B
Income tax expense
140.65M
243.24M
384.49M
495.18M
Effective tax rate
24.22%
25.29%
26.58%
26.94%
Other operating expenses
343.66M
460.68M
434.98M
515.10M
Net income
442.93M
722.41M
1.08B
1.32B
Net profit margin
21.37%
23.59%
27.46%
30.45%
Earnings per share
5.41
8.82
13.10
16.04
Interest and investment income
-
-
-
-
Interest expense
-6.38M
-5.79M
-8.61M
-11.90M
Net interest expenses
-6.38M
-5.79M
-8.61M
-11.90M
Depreciation and amortization charges
81.31M
84.02M
98.25M
96.30M
EBITDA
494.32M
951.87M
1.47B
1.83B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer